Loading...
Outcomes of mecom rearranged AML undergoing intensive chemotherapy in the NCRI AML17 and AML19 trials
Dennis, M. Othman, J. Canham, J. Thomas, I. Johnson, S. Telford, N. Harrison, B. Ramachandran, J. Cavenagh, J. Arnold, C.
Dennis, M.
Othman, J.
Canham, J.
Thomas, I.
Johnson, S.
Telford, N.
Harrison, B.
Ramachandran, J.
Cavenagh, J.
Arnold, C.
Abstract
Description
Date
2025
Publisher
Collections
Files
Loading...
Found from Unpaywall
Adobe PDF, 169.22 KB
Keywords
Type
Article
Citation
Dennis M, Othman J, Canham J, Thomas I, Johnson S, Telford N, et al. Outcomes of mecom rearranged AML undergoing intensive chemotherapy in the NCRI AML17 and AML19 trials. Blood. 2025 NOV 3;146:3435-6.